Isracann Biosciences (TSE:IPOT)
CNQX:IPOT
Canadian Market

Isracann Biosciences (IPOT) Income Statement

37 Followers

Isracann Biosciences Income Statement

Last quarter (Q4 2022), Isracann Biosciences's total revenue was C$―, a decrease of ― from the same quarter last year. In Q4, Isracann Biosciences's net income was C$-316.00K. See Isracann Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
May 22May 21May 20May 19May 18
Total Revenue
---C$ 0.00C$ 0.00C$ 1.17M
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 1.80MC$ 2.46MC$ 4.93MC$ 11.77MC$ 5.66MC$ 7.46M
Operating Income
C$ -1.80MC$ -2.46MC$ -4.93MC$ -11.77MC$ -5.66MC$ -6.28M
Net Non Operating Interest Income Expense
C$ 48.30KC$ 79.57KC$ 63.70KC$ 139.81KC$ 62.88KC$ -120.07K
Other Income Expense
C$ -48.13KC$ 89.52KC$ -20.09MC$ -12.35MC$ -3.76MC$ -1.07M
Pretax Income
C$ -1.81MC$ -4.69MC$ -25.09MC$ -23.99MC$ -5.60MC$ -7.47M
Tax Provision
--C$ 31.03KC$ -68.50KC$ 0.00C$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -1.81MC$ -4.69MC$ -25.16MC$ -24.20MC$ -9.60MC$ -7.47M
Basic EPS
C$ -0.01C$ -0.03C$ -0.18C$ -0.26C$ -0.27C$ -0.33
Diluted EPS
C$ -0.01C$ -0.03C$ -0.18C$ -0.26C$ -0.27C$ -0.33
Basic Average Shares
C$ 450.62MC$ 147.75MC$ 138.40MC$ 92.76MC$ 38.31MC$ 22.62M
Diluted Average Shares
C$ 450.62MC$ 147.75MC$ 138.40MC$ 92.76MC$ 38.31MC$ 22.62M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 1.80MC$ 2.46MC$ -4.93MC$ 11.77MC$ 5.66MC$ 7.46M
Interest Expense
---C$ 0.00C$ 0.00C$ 120.07K
Net Income From Continuing And Discontinued Operation
C$ -1.81MC$ -4.69MC$ -25.16MC$ -24.20MC$ -9.90MC$ -7.47M
Normalized Income
C$ -1.71MC$ -1.22MC$ 43.13MC$ -11.60MC$ -5.60MC$ -6.40M
EBIT
C$ -1.81MC$ -4.68MC$ -24.67MC$ -23.99MC$ -5.66MC$ -7.35M
EBITDA
C$ -1.78MC$ -4.64MC$ -24.63MC$ -23.94MC$ -5.62MC$ -6.77M
Currency in CAD

Isracann Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis